0000899243-23-010596.txt : 20230404
0000899243-23-010596.hdr.sgml : 20230404
20230404211959
ACCESSION NUMBER: 0000899243-23-010596
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230401
FILED AS OF DATE: 20230404
DATE AS OF CHANGE: 20230404
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LIU JEAN I
CENTRAL INDEX KEY: 0001241357
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-32405
FILM NUMBER: 23800975
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Seagen Inc.
CENTRAL INDEX KEY: 0001060736
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 911874389
STATE OF INCORPORATION: WA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4255274000
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
FORMER COMPANY:
FORMER CONFORMED NAME: SEATTLE GENETICS INC /WA
DATE OF NAME CHANGE: 20001116
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-04-01
0
0001060736
Seagen Inc.
SGEN
0001241357
LIU JEAN I
21823 30TH DRIVE SE
BOTHELL
WA
98021
0
1
0
0
Chief Legal Officer
0
Common Stock
2023-04-01
4
A
0
1389
0.00
A
86502
D
These restricted stock units will be settled in common stock upon vesting.
The restricted stock units shall vest 37.5% on the 18 month anniversary of the grant date, 31.25% on the 24 month anniversary of the grant date, and 31.25% on the 30 month anniversary of the grant date.
Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
By: /s/ Jennifer Prosba For: Jean I. Liu
2023-04-04